An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology 1
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in a1
On World Cancer Day, held every year on 4 February, Clínic Barcelona Comprehensive Cancer Centre (4CB) highlights its excellence in patient care1
Elías Campo, head of the Molecular Pathology of Lymphoid Neoplasias research group at IDIBAPS, has received a “Proof of Concept Grant” from the Europ1
On 14 January, the launch meeting of the European project CINNAMON (Connecting an INternational Network of Academic Manufacturers of ONcoimmunot1
Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer Cen1
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastu1
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Annua1
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordinat1
Today, 17 November, we mark World Lung Cancer Day — an occasion to raise awareness of this disease, acknowledge the efforts of patients and families,1
